1,230
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Co-targeting p53-R249S and CDK4 synergistically suppresses survival of hepatocellular carcinoma cells

, , &
Pages 269-277 | Received 08 Jan 2019, Accepted 22 Oct 2019, Published online: 21 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jia-Ning Zhang, Feng Wei, Lin-Han Lei, Yang Yang, Yuan Yang & Wei-Ping Zhou. (2021) Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis. Bioengineered 12:2, pages 11728-11739.
Read now

Articles from other publishers (6)

Qifei Tian, Guofang Lu, Ying Ma, Lingling Ma, Yulong Shang, Ni Guo, Yan Huang, Lin Zhu & Rui Du. (2023) Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC. Aging.
Crossref
Ran Chen, Moubin Lin & Daming Gao. (2023) Major genomic mutations driving hepatocellular carcinoma. Genome Instability & Disease.
Crossref
Sisi Qin, Ichiwa Kitty, Yalan Hao, Fei Zhao & Wootae Kim. (2023) Maintaining Genome Integrity: Protein Kinases and Phosphatases Orchestrate the Balancing Act of DNA Double-Strand Breaks Repair in Cancer. International Journal of Molecular Sciences 24:12, pages 10212.
Crossref
Maria J. Solares & Deborah F. Kelly. (2022) Complete Models of p53 Better Inform the Impact of Hotspot Mutations. International Journal of Molecular Sciences 23:23, pages 15267.
Crossref
Zhong-liu Wei, Xin Zhou, Chen-lu Lan, Hua-sheng Huang, Xi-wen Liao, Shu-tian Mo, Yong-guang Wei & Tao Peng. (2022) Clinical implications and molecular mechanisms of Cyclin-dependent kinases 4 for patients with hepatocellular carcinoma. BMC Gastroenterology 22:1.
Crossref
Sufeng Zhao, Li An, Xudong Yang, Zheng Wei, He Zhang & Yufeng Wang. (2022) Identification and validation of the role of c-Myc in head and neck squamous cell carcinoma. Frontiers in Oncology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.